Skip to main content
Loading ResearchHub…
Cited by — Pediatric Brain Tumor Consortium Phase I Study of CD40 Agonist Sotigalimab in Pediatric and Young Adult Patients with Recurrent CNS Tumors and Newly Diagnosed DIPG | ResearchHub - ResearchHub